Triumph Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Triumph Capital Management's GSK Position: Q3 2026 in Review
Triumph Capital Management reduced its GSK (GSK) stake by 9.9% in Q3 2026, selling an estimated $4.95K and leaving 886 shares worth $42.7K. The position accounts for 0.01% of the portfolio, ranked #743.
Triumph Capital Management first reported a position in GSK in Q2 2022 and has held it in 11 quarters since. The position peaked at $641K in Q3 2022. 870 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Triumph Capital Management held 886 shares of GSK worth $42.7K as of Q3 2026.
- Triumph Capital Management sold 97 GSK shares in Q3 2026, an estimated $4.95K.
- GSK made up 0.01% of Triumph Capital Management's portfolio in Q3 2026, its #743 holding.
- Triumph Capital Management first reported a position in GSK in Q2 2022 and has held it in 11 quarters since.
- Triumph Capital Management's GSK position peaked at $641K in Q3 2022.
- 870 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.